Tianjin Pharmaceutical Da Ren Tang Group Corporation Limited (600329.SS) SHH
Currency In CNY
AD
- General
- Statistics
- Historical Data
- Profile
- Financials
Valuation
| Market Cap | 35.1B |
| Enterprise Value | 34.14B |
| P/E Ratio | 37.17 |
| PEG Ratio | -0.49 |
| Price/Sales Ratio | 4.95 |
| Price/Book Ratio | 5.31 |
| Enterprise/Revenue | 4.45 |
| Enterprise/EBITDA | 19.91 |
Fiscal Year
| Fiscal Year | December 31, 2025 |
| Most Recent Quarter | June 30, 2026 |
Profitability
| Profit Margin | 0.18 |
| Operating Margin | 0.18 |
AD
Management Effectiveness
| Return On Assets | 0.08 |
| Return On Equity | 0.11 |
Income Statement
| Revenue | 4.92B |
| Revenue/Share | 6.13 |
| Gross Profit | 3.64B |
| EBITDA | 2.61B |
| Net Income | 2.13B |
| Diluted EPS | 2.77 |
Balance Sheet
| Total Cash | 3.53B |
| Total Cash/Share | 4.59 |
| Total Debt | 98.34M |
| Total Debt/Equity | 0.02 |
| Current Ratio | 1.38 |
| Book Value Per Share | 7.72 |
Price History
| 52-Week Change | -5.03 |
| 52-Week High | 50.95 |
| 52-Week Low | 33.83 |
| Moving Average 50 Days | 36 |
| Moving Average 200 Days | 39.73 |
Statistics
| Average Volume | 3.07M |
| Shares Outstanding | 570.09M |
| % Held by Institutions | N/A |
Dividend And Splits
| Trailing Annual Dividend Rate | 4.79 |
| Trailing Annual Dividend Yield | 11.69 |
| Payout Ratio | 2.21 |
| Last Split Factor | 2:1 |
| Last Split Date | July 05, 2010 |
AD
